Liu Y - Search Results

1

MicroRNA-146a feedback suppresses T cell immune function by targeting Stat1 in patients with chronic hepatitis B.

Wang S, Zhang X, Ju Y, Zhao B, Yan X, Hu J, Shi L, Yang L, Ma Z, Chen L, Liu Y, Duan Z, Chen X, Meng S. Wang S, et al. Among authors: liu y. J Immunol. 2013 Jul 1;191(1):293-301. doi: 10.4049/jimmunol.1202100. Epub 2013 May 22. J Immunol. 2013. PMID: 23698745

2

Keratin 18 phosphorylation as a progression marker of chronic hepatitis B.

Shi Y, Sun S, Liu Y, Li J, Zhang T, Wu H, Chen X, Chen D, Zhou Y. Shi Y, et al. Among authors: liu y. Virol J. 2010 Mar 24;7:70. doi: 10.1186/1743-422X-7-70. Virol J. 2010. PMID: 20334631 Free PMC article.

3

[Responsive factors and predictors of interferon treatment in patients with chronic hepatitis B].

Liu YL, Chen XY. Liu YL, et al. Zhonghua Gan Zang Bing Za Zhi. 2010 Jun;18(6):410-3. doi: 10.3760/cma.j.issn.1007-3418.2010.06.004. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20587308 Chinese. No abstract available.

4

[Higher dose of interferon treatment of chronic hepatitis C patient with primary non-response: a case report].

Liu YL, Chen XY. Liu YL, et al. Zhonghua Gan Zang Bing Za Zhi. 2010 Dec;18(12):950. doi: 10.3760/cma.j.issn.1007-3418.2010.12.020. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 21205489 Chinese. No abstract available.

5

Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients.

Zhang Y, Liu Y, Zhao Y, Shi L, Ma L, Yan H, Wu H, Wei L, Dong T, Chen X. Zhang Y, et al. Among authors: liu y. Liver Int. 2012 Jan;32(1):102-9. doi: 10.1111/j.1478-3231.2011.02652.x. Epub 2011 Sep 26. Liver Int. 2012. PMID: 22098382

6

[The clinical significance of PreS1Ag and anti-PreS1 in patients with chronic hepatitis B].

Zhang XD, Ren S, Yu HB, Liu YL, Jin Y, Huang YX, Chen JM, Chen XY. Zhang XD, et al. Among authors: liu yl. Zhonghua Gan Zang Bing Za Zhi. 2011 Sep;19(9):674-7. doi: 10.3760/cma.j.issn.1007-3418.2011.09.010. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22152382 Chinese.

7

[Efficacy of low-dose interferon therapy for treating chronic hepatitis C patients who cannot tolerate standard treatment].

Cao ZH, Liu YL, Zheng YH, Ji SD, Wang JL, Liao JH, Zhang CY, Chen XY. Cao ZH, et al. Zhonghua Gan Zang Bing Za Zhi. 2012 Jan;20(1):20-4. doi: 10.3760/cma.j.issn.1007-3418.2012.01.008. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 22464701 Clinical Trial. Chinese.

8

[Efficacy and safety of peginterferon alfa-2a (40 kd) plus adefovir for 96 weeks in HBeAg-negative chronic hepatitis B patients].

Cao ZH, Ma LN, Liu YL, Jin Y, He ZM, Lu JF, Zhang YH, Chen XY. Cao ZH, et al. Among authors: liu yl. Zhonghua Gan Zang Bing Za Zhi. 2013 Jul;21(7):498-501. doi: 10.3760/cma.j.issn.1007-3418.2013.07.006. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24074706 Clinical Trial. Chinese.

9

Bone marrow suppression or active proliferation? An analysis of neutropenia after pegylated interferon treatment of patients with chronic hepatitis C.

Liu YL, Du XF, Chen XY, Ma LN, Guo DD, Lu JF, Cao ZH, Zhang YH. Liu YL, et al. Scand J Infect Dis. 2013 Dec;45(12):939-43. doi: 10.3109/00365548.2013.835067. Epub 2013 Oct 3. Scand J Infect Dis. 2013. PMID: 24090457

10

[Changes in lymphocyte surface expression of CD8 and CD38 molecules in peripheral blood of inactive HBsAg carriers following pegylated interferon a-2a therapy].

Yu HB, Ma LN, Liu YL, Hua W, He ZM, Lu JF, Chen XY. Yu HB, et al. Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):895-8. doi: 10.3760/cma.j.issn.1007-3418.2013.12.004. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24636289 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208,930 results

Search Page

Filters